Last reviewed · How we verify
Disorder of electrolytes — Treatment Landscape & Competitive Intelligence
3 marketed
0 Phase 3
0 Phase 2
Live · 30-min refresh
Marketed treatment landscape
| Drug | Generic | Sponsor | Class | Target | Line of therapy | First approval |
|---|---|---|---|---|---|---|
| Phoslo | CALCIUM ACETATE | Fresenius Medcl Care | calcium acetate | 1982-01-01 | ||
| Calcium Gluceptate | calcium glucoheptonate | Abbott | calcium glucoheptonate | 1972-01-01 | ||
| Plegisol In Plastic Container | CALCIUM CHLORIDE | Pfizer | calcium chloride | 1971-01-01 |
Phase 3 pipeline
Phase 2 pipeline
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Sponsor landscape
- · 2 drugs in Disorder of electrolytes
- Abbott · 1 drug in Disorder of electrolytes
- Fresenius Medcl Care · 1 drug in Disorder of electrolytes
- Pfizer · 1 drug in Disorder of electrolytes
Subscribe to ongoing alerts
Every new regulatory action, PDUFA date, or trial completion in Disorder of electrolytes:
- Disorder of electrolytes treatment updates — RSS
- Disorder of electrolytes treatment updates — Atom
- Disorder of electrolytes treatment updates — JSON
Cite this brief
Drug Landscape (2026). Disorder of electrolytes — Treatment Landscape & Competitive Intelligence Brief. https://druglandscape.com/ci/disease/disorder-of-electrolytes. Accessed 2026-06-10.
Related
- Disorder of electrolytes full disease profile — treatment pathway, diagnostics, guidelines
- Browse all CI briefs
- Build a custom feed
Primary sources · FDA · ClinicalTrials.gov · EMA · SEC EDGAR · ChEMBL · Wikidata · full sourcing